CapsoVision (CV) vs electroCore (ECOR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
electroCore (ECOR) has outperformed CapsoVision (CV) over the past year, gaining 96.4% versus a gain of 38.9%. CapsoVision is the larger company by market cap ($348.0 million vs $87.6 million), about 4.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CV | ECOR |
|---|---|---|
| Share price | $6.54 | $9.72 |
| Market cap | $348.00M | $87.63M |
| 1-day change | +0.62% | -2.02% |
| YTD return | -38.82% | +116.72% |
| 1-year return | +38.85% | +96.36% |
| 5-year return | — | -35.01% |
| EPS (TTM) | $-0.45 | $-1.65 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $15.37 | $12.70 |
| 52-week low | $4.38 | $4.41 |
| Distance from 52-week high | -57.45% | -23.46% |
| Analyst consensus | strong_buy | — |
| Avg. price target upside | +45.26% | — |
| Average volume | 158.95K | 82.66K |
| Shares outstanding | 53.21M | 9.02M |
| Employees | 99 | — |
| Sector | Healthcare | Health Care |
| Industry | Medical Devices | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CapsoVision is about 4.0 times larger than electroCore by market value ($348.00M vs $87.63M).
- ECOR has outperformed CV by 57.5 percentage points over the past year.
- The two companies sit in different sectors: CapsoVision in Healthcare and electroCore in Health Care.
About CapsoVision
CV stock →CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon).
Healthcare · Medical Devices · 99 employees
CV vs ECOR FAQ
Which is bigger, CapsoVision or electroCore?
CapsoVision (CV) is larger, with a market capitalization of $348.00M compared with $87.63M for electroCore (ECOR).
Which stock has performed better over the past year, CV or ECOR?
ECOR returned +96.36% over the past 12 months, compared with +38.85% for CV (price return, excluding dividends). Past performance does not predict future results.
Are CapsoVision and electroCore in the same industry?
No. CapsoVision is in the Healthcare sector, while electroCore is in Health Care.